BioSpace News Archive

Plandai Biotechnology, Inc. announces the rescission of a material definitive agreement with Good Salt, LLC due to the material failure of consideration in the transaction.

Theriva Biologics announced that it plans to host a conference call on Tuesday, August 8, 2023, at 8:30 a.m. ET to discuss its financial results for the quarter ended June 30, 2023 and provide a corporate update.

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report second quarter 2023 financial results and corporate highlights after the U.S. financial markets close on Tuesday, August 8, 2023.

Bausch + Lomb Corporation today announced changes to its executive leadership team including the creation of two new roles.

Specialty cancer diagnostics company Precipio, Inc., announces that Q2-2023 revenues have increased to $3.5M in Q2-2023 from $2.8M in Q1-2023, an increase of 25% QoQ.

Cadrenal Therapeutics, Inc. today announced that the Company is expanding its focus for tecarfarin to patients with implanted medical devices.

Medis, the leading commercialization company focused on improving access to innovative therapies in the countries of Central and Eastern Europe

Centinel Spine®, LLC announced record second quarter 2023 financial results in both revenue growth and profitability.

Alpenglow Biosciences has been awarded a $1.6M grant to develop artificial intelligence (AI) enabled smart microscopy using its patented multi-resolution 3Di platform for 3D spatial biology.

AXIM Biotechnologies, Inc announced today the receipt of notification by the United States Patent & Trademark Office of several patent allowances.